Immune thrombocytopenia (ITP): vizsgálatok itt: Görögország
5 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Patras, Thessaloniki
- Életkor
- 18 év and over
- People
- 171 worldwide
- Run by
- Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00 - 3. fázisTaking peopleA Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Where
- Patras, Thessaloniki
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00 - 2. fázisTaking peopleSafety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia
- Where
- Patra, Thessaloniki
- Életkor
- 18 év to 80 év
- People
- 30 worldwide
- Run by
- Nuvig Therapeutics, Inc.
See details and how to joinNCT07095127 · EU 2024-520359-26-00 - 1/2. fázisTaking peopleA Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)
- Where
- Athens, Chaïdári, Ioannina, Thessaloniki
- Életkor
- 18 év and over
- People
- 24 worldwide
- Run by
- Climb Bio, Inc.
See details and how to joinNCT07043946 - 2. fázisNot yet taking people in GörögországA PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY
- Where
- Athens, Thessaloniki
- Életkor
- 18 év and over
- People
- 14
- Run by
- Hellenic Society of Hematology
See details and how to joinNCT07019545 · EU 2023-509131-12-01